tiprankstipranks
Trending News
More News >
Religare Enterprises Limited (IN:RELIGARE)
:RELIGARE
India Market

Religare Enterprises Limited (RELIGARE) AI Stock Analysis

Compare
2 Followers

Top Page

IN:RELIGARE

Religare Enterprises Limited

(RELIGARE)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
₹266.00
▲(13.63% Upside)
Religare Enterprises' overall stock score is driven by strong financial performance, particularly in revenue growth and cash flow management. However, high valuation metrics and neutral technical indicators limit the score. The absence of earnings call data and corporate events means these factors do not influence the score.
Positive Factors
Revenue Growth
The company's robust revenue growth indicates expanding market presence and effective product offerings, supporting long-term business sustainability.
Cash Flow Management
Strong cash generation capabilities ensure the company can fund operations, invest in growth opportunities, and maintain financial flexibility.
Balance Sheet Health
A stable balance sheet with healthy equity and liquidity positions the company well to withstand economic fluctuations and pursue strategic initiatives.
Negative Factors
Profitability Challenges
Low profitability and return on equity suggest inefficiencies that could limit future growth and shareholder returns if not addressed.
Net Profit Margin Decline
Declining net profit margins from rising expenses can pressure overall profitability, necessitating cost management improvements for sustainable growth.
Earnings Volatility
Negative EPS growth reflects earnings volatility, which can undermine investor confidence and affect the company's ability to attract capital.

Religare Enterprises Limited (RELIGARE) vs. iShares MSCI India ETF (INDA)

Religare Enterprises Limited Business Overview & Revenue Model

Company DescriptionReligare Enterprises Limited operates as an investment company in India and internationally. The company provides broking services in equities, currencies, and commodities; depository participant services; tax information network and income tax permanent account number facilities; and tax deduction at source/tax collection at source filing services, as well as operates as an NSDL-appointed enrolment agency for Aadhaar unique identification number and an AMFI-registered mutual fund distributor. It also offers finance for small and medium enterprises; and housing finance, including home-purchase, home construction, and home improvement loans. In addition, the company provides e-governance and financial advisory services; and issues digital signature certificate. Further, it offers health insurance services to employees of corporates, and individual customers. Additionally, the company provides critical illness, personal accident, top-up coverage, international travel, and maternity insurance products, as well as group health and personal accident insurance. Religare Enterprises Limited was incorporated in 1984 and is based in New Delhi, India.
How the Company Makes MoneyReligare Enterprises generates revenue through several key streams. Its primary revenue sources include brokerage fees from retail and institutional clients engaged in stock trading, management fees from its asset management division, and premiums collected from its insurance products. Additionally, the company earns interest income from its lending operations, which involves providing personal loans, business loans, and other financing solutions. Strategic partnerships with financial institutions and technology firms enhance RELIGARE's capabilities and reach, contributing to its overall revenue growth. The company also focuses on enhancing its digital platforms to attract more customers and streamline its service delivery, further bolstering its earnings potential.

Religare Enterprises Limited Financial Statement Overview

Summary
Religare Enterprises shows strong revenue growth and efficient cash flow management, indicating operational resilience. However, challenges with profitability and return on equity may hinder future growth. The balance sheet is stable with adequate liquidity and balanced leverage.
Income Statement
78
Positive
Religare Enterprises has demonstrated robust revenue growth, with a significant increase from 2024 to 2025. The gross profit margin remains high, indicating effective cost management. However, the net profit margin has declined due to increased operating expenses, affecting overall profitability. The EBIT margin showed a positive trend, reflecting improved operational efficiency.
Balance Sheet
65
Positive
The company's balance sheet shows a moderate debt-to-equity ratio, suggesting balanced leverage. The equity ratio is healthy, indicating a strong equity base relative to total assets. However, the return on equity is low, pointing to inefficiencies in generating returns on shareholder investments. Liquidity appears sufficient with ample cash reserves.
Cash Flow
83
Very Positive
Cash flow analysis reveals strong operating cash flow, consistent with a positive trend in free cash flow, indicating solid cash generation capabilities. The operating cash flow to net income ratio is favorable, showcasing effective cash management. However, the free cash flow growth rate is modest, suggesting limited growth in cash surplus.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue58.79B73.18B61.91B43.19B31.89B24.01B
Gross Profit51.71B48.64B40.74B36.93B24.49B16.81B
EBITDA3.02B3.39B6.10B39.41B-2.38B2.81B
Net Income1.18B1.25B2.33B869.31M-15.44B-5.08B
Balance Sheet
Total Assets0.00112.29B95.77B80.94B93.53B87.26B
Cash, Cash Equivalents and Short-Term Investments0.0010.87B10.72B7.98B25.26B16.20B
Total Debt0.002.33B4.43B8.41B49.37B49.40B
Total Liabilities-34.37B77.92B64.08B54.16B98.85B84.28B
Stockholders Equity34.37B25.16B23.43B20.58B-9.82B-470.86M
Cash Flow
Free Cash Flow0.0015.47B14.78B14.66B15.56B13.54B
Operating Cash Flow0.0015.72B15.00B15.06B15.96B13.73B
Investing Cash Flow0.00-11.85B-13.48B-9.39B-6.89B-11.81B
Financing Cash Flow0.00-2.85B-1.56B-20.79B5.59B-3.14B

Religare Enterprises Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price234.10
Price Trends
50DMA
250.14
Negative
100DMA
251.68
Negative
200DMA
241.99
Negative
Market Momentum
MACD
-6.35
Negative
RSI
45.16
Neutral
STOCH
47.03
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RELIGARE, the sentiment is Negative. The current price of 234.1 is below the 20-day moving average (MA) of 235.76, below the 50-day MA of 250.14, and below the 200-day MA of 241.99, indicating a bearish trend. The MACD of -6.35 indicates Negative momentum. The RSI at 45.16 is Neutral, neither overbought nor oversold. The STOCH value of 47.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:RELIGARE.

Religare Enterprises Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
₹80.65B6.642.16%7.08%7.69%
77
Outperform
₹104.68B7.711.00%8.09%2.68%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
62
Neutral
₹77.43B73.678.35%-50.99%
60
Neutral
₹104.75B25.092.78%6.15%-64.12%
56
Neutral
₹67.11B-73.601.72%10.02%-120.18%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:RELIGARE
Religare Enterprises Limited
234.10
-74.35
-24.10%
IN:EQUITASBNK
Equitas Small Finance Bank Ltd.
58.83
-6.44
-9.87%
IN:KTKBANK
Karnataka Bank Ltd.
200.50
-1.78
-0.88%
IN:SOUTHBANK
South Indian Bank Limited
40.00
15.34
62.21%
IN:TMB
Tamilnad Mercantile Bank Limited
509.30
59.58
13.25%
IN:UJJIVANSFB
Ujjivan Small Finance Bank Ltd.
54.04
20.44
60.83%

Religare Enterprises Limited Corporate Events

Religare Enterprises Opens Special Window for Share Transfer Requests
Nov 22, 2025

Religare Enterprises Limited announced a special window for shareholders to re-lodge transfer requests of physical shares that were previously rejected or unattended due to document deficiencies. This initiative, following a SEBI circular, aims to address past administrative issues, potentially improving shareholder satisfaction and operational efficiency.

Religare Enterprises Releases Q2 FY2026 Financial Performance Presentation
Nov 13, 2025

Religare Enterprises Limited has released an investor presentation detailing its operational and financial performance for the quarter and half year ending September 30, 2025. The presentation, which is available on the company’s website, is part of the preparations for an upcoming earnings call. This announcement is significant as it provides stakeholders with insights into the company’s recent performance and strategic direction.

Religare Enterprises Confirms SEBI Compliance for Q3 2025
Oct 14, 2025

Religare Enterprises Limited announced its compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending September 30, 2025. This compliance, confirmed by KFin Technologies Limited, ensures that the company’s securities dematerialization processes are in line with regulatory standards, potentially enhancing stakeholder confidence in its operational integrity.

Religare’s Subsidiary Faces Confirmed GST Demand and Penalty
Oct 1, 2025

Religare Enterprises Limited has announced that its subsidiary, Care Health Insurance Ltd. (CHIL), has received a confirmation from the Joint Commissioner, Common Adjudicating Authority, CGST Commissionerate, Faridabad, regarding a GST demand of ₹35.92 crore, along with a penalty and applicable interest for the period from July 2017 to March 2022. This confirmation follows a directive from the Bombay High Court to reassess a previous order related to industry-wide issues concerning non-payment of GST on co-insurance and re-insurance transactions. The company plans to appeal or consider other actions against this order.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 10, 2025